During a 30-year period, 323 SSc patients were admitted to a tertiary center specialized in connective tissue diseases. Among them 13 (4|X%) developed scleroderma renal crisis (SRC). These 13 SRC patients with respect to the remaining SSc patients were older, were more often affected by diffuse cutaneous systemic sclerosis (dcSSc), and had slightly higher blood pressure and more frequent heart involvement at initial presentation. Among the 13 SRC patients, an older age, a shorter disease duration, and a higher peak serum creatinine correlated with a poor outcome.SRC in Italian patients showed a lower prevalence (4|X%) than in many earlier reports. Mean survival in SRC patients was 6 years. This tended to be less than the 16.5 yea...
Objective. Scleroderma renal crisis (SRC) is a severe manifestation of SSc, whose prognosis remains ...
The aim of this study was to evaluate systemic sclerosis (SSc) hospitalizations through a retrospect...
BackgroundDespite the efficacy of angiotensin-converting enzyme (ACE) inhibitors, the prognosis of p...
During a 30-year period, 323 SSc patients were admitted to a tertiary center specialized in connect...
Objective. To analyze clinical and serological characteristics of subjects with seleroderma renal cr...
OBJECTIVE: To analyze clinical and serological characteristics of subjects with scleroderma renal cr...
Scleroderma renal crisis (SRC) is a major complication in patients with systemic sclerosis. SRC occu...
OBJECTIVE: To analyze clinical and serological characteristics of subjects with scleroderma renal c...
Scleroderma renal crisis (SRC) is a major complication in patients with systemic sclerosis (SSc). It...
To date, scleroderma renal crisis (SRC) remains a life-threatening complication in patients affected...
Objectives: To describe presentation and outcome of patients with scleroderma renal crisis (SRC). Me...
Scleroderma renal crisis (SRC) was known as a rare and catastrophic syndrome responsible for acute r...
The UK Scleroderma Study Group developed guidelines on the diagnosis and management of scleroderma r...
Background: Scleroderma renal crisis (SRC) is a rare but feared complication of scleroderma. Angiote...
Data for outcomes of patients with end-stage renal disease (ESRD) secondary to systemic sclerosis (s...
Objective. Scleroderma renal crisis (SRC) is a severe manifestation of SSc, whose prognosis remains ...
The aim of this study was to evaluate systemic sclerosis (SSc) hospitalizations through a retrospect...
BackgroundDespite the efficacy of angiotensin-converting enzyme (ACE) inhibitors, the prognosis of p...
During a 30-year period, 323 SSc patients were admitted to a tertiary center specialized in connect...
Objective. To analyze clinical and serological characteristics of subjects with seleroderma renal cr...
OBJECTIVE: To analyze clinical and serological characteristics of subjects with scleroderma renal cr...
Scleroderma renal crisis (SRC) is a major complication in patients with systemic sclerosis. SRC occu...
OBJECTIVE: To analyze clinical and serological characteristics of subjects with scleroderma renal c...
Scleroderma renal crisis (SRC) is a major complication in patients with systemic sclerosis (SSc). It...
To date, scleroderma renal crisis (SRC) remains a life-threatening complication in patients affected...
Objectives: To describe presentation and outcome of patients with scleroderma renal crisis (SRC). Me...
Scleroderma renal crisis (SRC) was known as a rare and catastrophic syndrome responsible for acute r...
The UK Scleroderma Study Group developed guidelines on the diagnosis and management of scleroderma r...
Background: Scleroderma renal crisis (SRC) is a rare but feared complication of scleroderma. Angiote...
Data for outcomes of patients with end-stage renal disease (ESRD) secondary to systemic sclerosis (s...
Objective. Scleroderma renal crisis (SRC) is a severe manifestation of SSc, whose prognosis remains ...
The aim of this study was to evaluate systemic sclerosis (SSc) hospitalizations through a retrospect...
BackgroundDespite the efficacy of angiotensin-converting enzyme (ACE) inhibitors, the prognosis of p...